Mutations associated with Sjögren-Larsson syndrome

Area of Science:

• Biochemistry
• Genetics
• Molecular Biology

Background:

• Sjögren-Larsson syndrome (SLS) is a rare autosomal disorder featuring ichthyosis, spastic neurological deficits, and intellectual disability.
• SLS is associated with a deficiency in fatty aldehyde dehydrogenase (ALDH10), encoded by a gene on chromosome 17q11.2.
• The ALDH3 isozyme, also involved in fatty aldehyde oxidation and located on chromosome 17q11.2, was investigated as a potential cause for similar syndromes.

Purpose of the Study:

• To investigate mutations in the ALDH3 and ALDH10 genes in Sjögren-Larsson syndrome patients.
• To differentiate between ALDH3 and ALDH10 gene abnormalities as causes of SLS.
• To characterize the specific genetic mutations underlying SLS.

Main Methods:

• Genetic analysis of the ALDH3 and ALDH10 loci in SLS patients.
• Mutation screening using techniques like sequencing and isoelectric focusing.
• Analysis of ALDH10 mRNA levels in patient-derived fibroblast cells.

Main Results:

• No causative mutations were found in the ALDH3 gene; identified variations were common in healthy individuals.
• Fibroblast cells from SLS patients showed diminished ALDH10 expression and reduced ALDH10 mRNA levels.
• Specific ALDH10 mutations identified include a combined deletion-insertion at intron 6/exon 7, a 2-base deletion causing premature termination, and a compound heterozygote mutation.

Conclusions:

• SLS is primarily caused by mutations in the ALDH10 gene, not ALDH3.
• The identified ALDH10 mutations lead to reduced enzyme expression and function, characteristic of SLS.
• Detailed characterization of these unique SLS-associated ALDH10 mutations provides insight into the syndrome's molecular basis.